Skip to main content
. 2023 Jul 27;14:1237361. doi: 10.3389/fimmu.2023.1237361

Figure 6.

Figure 6

Schematic illustration of the process of preparation of CM@Mn nanozyme and the therapeutic strategy of TME-activable manganese-boosted catalytic immunotherapy combined with PD-1 checkpoint blockade (73).